col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

SAGE Publications: Multiple Sclerosis Journal
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―09 Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic Zoë YGJ van Lierop, Alyssa A Toorop, Wouter JC van Ballegoij, Tom BG Olde Dubbelink, Eva MM Strijbis, Brigit A de Jong, et al. (+6)
2 [GO] 2021―Jul―02 Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry Tim Spelman, Lars Forsberg, Kyla McKay, Anna Glaser, Jan Hillert
3 [GO] 2021―Jun―08 Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patient Bianca Weinstock-Guttman, Dejan Jakimovski
4 [GO] 2021―Jun―04 Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register Afagh Garjani, Rachael Hunter, Graham R Law, Rodden M Middleton, Katherine A Tuite-Dalton, Ruth Dobson, et al. (+9)
5 [GO] 2021―Apr―15 COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021 Anat Achiron, Mark Dolev, Shay Menascu, Daniela-Noa Zohar, Sapir Dreyer-Alster, Shmuel Miron, et al. (+9)
6 [GO] 2021―Mar―25 Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey Emilio Portaccio, Mattia Fonderico, Bernhard Hemmer, Tobias Derfuss, Bruno Stankoff, Krzysztof Selmaj, et al. (+2)
7 [GO] 2021―Feb―02 Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis
8 [GO] 2020―Nov―18 COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments Alice Laroni, Irene Schiavetti, Maria Pia Sormani, Antonio Uccelli
9 [GO] 2020―Oct―16 Lymphocyte counts and the risk of COVID-19 in people with MS Nikos Evangelou, Afagh Garjani
10 [GO] 2020―Oct―16 Response to letter ‘Lymphocyte counts and the risk of COVID-19 in people with MS’ Floor C Loonstra, Zoé LE van Kempen, Eva M Strijbis, Joep Killestein, Elske Hoitsma, Jop P Mostert
11 [GO] 2020―Sep―14 Response of the multiple sclerosis community to COVID-19 Olga Ciccarelli, Jeffrey A Cohen, Alan Thompson
12 [GO] 2020―Sep―10 COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence? - Commentary Cristina Valencia-Sanchez, Eoin P Flanagan
13 [GO] 2020―Sep―10 COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence? Diogo Goulart Corrêa, Fabiana Cavalcanti de Souza Lima, Daniel da Cruz Bezerra, Antônio Carlos Coutinho, Luiz Celso Hygino da Cruz
14 [GO] 2020―Aug―17 MS, pregnancy and COVID-19 Charmaine Yam, Vilija Jokubaitis, Kerstin Hellwig, Ruth Dobson
15 [GO] 2020―Aug―10 Multiple sclerosis management during the COVID-19 pandemic Brandon P Moss, Kedar R Mahajan, Robert A Bermel, Kelsey Hellisz, Le H Hua, Timothy Hudec, et al. (+20)
16 [GO] 2020―Aug―07 COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual? Wallace J Brownlee
17 [GO] 2020―Aug―07 Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient Hannah Wurm, Kate Attfield, Astrid KN Iversen, Ralf Gold, Lars Fugger, Aiden Haghikia
18 [GO] 2020―Aug―07 COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment Rick Dersch, Thomas Wehrum, Sebastian Fähndrich, Monika Engelhardt, Sebastian Rauer, Benjamin Berger
19 [GO] 2020―Jul―14 COVID-19 in multiple sclerosis: The Dutch experience Floor C Loonstra, Elske Hoitsma, Zoé LE van Kempen, Joep Killestein, Jop P Mostert
20 [GO] 2020―Jul―14 COVID-19 in people with multiple sclerosis: A global data sharing initiative Liesbet M Peeters, Tina Parciak, Clare Walton, Lotte Geys, Yves Moreau, Edward De Brouwer, et al. (+42)
21 [GO] 2020―Jun―22 COVID-19 will change MS care forever - Commentary SC Krieger
22 [GO] 2020―Jun―22 COVID-19 will change MS care forever - No Paolo Preziosa, Maria A Rocca, Massimo Filippi
23 [GO] 2020―Jun―22 COVID-19 will change MS care forever - Yes Virginia Meca-Lallana
24 [GO] 2020―Jun―19 Keeping standards of multiple sclerosis care through the COVID-19 pandemic Jaume Sastre-Garriga, Mar Tintoré, Xavier Montalban
25 [GO] 2020―May―28 Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression Tiziana Carandini, Anna Margherita Pietroboni, Luca Sacchi, Milena Alessandra De Riz, Mattia Pozzato, Andrea Arighi, et al. (+4)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.012 sec